ARCHIVES

Analysis Reveals CAIX Subgroup Responsive to Rencarex Therapy

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: Deadline June 1 For New ACS Prevention Awards; Money Available To Fund Five More

April 11, 1980

FDA Committee Agenda Includes M-AMSA, THC, Estramustine, Platinum

May 22, 1981

Constance Percy Retires From NCI After 30 Years.

November 10, 2000

In the Cancer Centers: Margaret Kripke of M.D. Anderson to Retire in 2007.

June 16, 2006

NCI-Approved Clinical Trials

July 29, 2005

Cost To Oncologist For Enrolling a Patient On Trial About $2,000, ASCO Survey Finds

June 11, 1999